We investigated whether angiotensin-(1-7) [Ang-(1-7)]-induced renal haemodynamic and excretory actions were solely dependent upon intrarenal Mas receptor activation or required functional angiotensin II type 1 (AT 1 ) receptors. The renin-angiotensin system was enhanced in anaesthetized rats by prior manipulation of dietary sodium intake. Angiotensin-(1-7) and AT 1 and Mas receptor antagonists were infused into the kidney at the corticomedullary border. Mas receptor expression was measured in the kidney. Mean arterial pressure, urine flow and fractional sodium excretion were 93 ± 4 mmHg, 46.1 ± 15.7 µl min −1 kg −1 and 1.4 ± 0.3%, respectively, in the normal-sodium group and 91 ± 2 mmHg, 19.1 ± 3.3 µl min −1 kg −1 and 0.7 ± 0.2%, respectively, in the low-sodium group. Angiotensin-(1-7) infusion had no effect on mean arterial pressure in rats receiving a normal-sodium diet but decreased it by 4 ± 5% in rats receiving a low-sodium diet (P < 0.05). Interstitial Ang-(1-7) infusion increased urine flow twofold and fractional sodium excretion threefold (P < 0.05) in rats receiving a normal-sodium diet and to a greater extent, approximately three-and fourfold, respectively, in rats receiving the low-sodium diet (both P < 0.05). Angiotensin-(1-7)-induced increases in urine flow and fractional sodium excretion were absent in both dietary groups during intrarenal AT 1 or Mas receptor inhibition after either losartan or A-779, respectively. Thus, AT 1 receptor activation, as well as Mas receptor activation, plays an essential role in mediating Ang-(1-7)-induced natriuresis and diuresis. Whether this is because Ang-(1-7) partly antagonizes AT 1 receptors or whether Ang-(1-7)-induced natriuresis is mediated through AT 1 -Mas receptor dimerization remains unclear.
Introduction
The natriuretic and haemodynamic actions of angiotensin-(1-7) [Ang-(1-7)] have been well studied by numerous investigators (Dellipizzi et al. 1994; Hilchey & Bell-Quilley, 1995; Bürgelová et al. 2002 Bürgelová et al. , 2005 Pinheiro et al. 2009 ). However, the factors that govern the interrelationship between renal Ang-(1-7) and angiotensin II (Ang II) and the precise roles played by the various angiotensin receptors in determining the regulation of renal excretory and haemodynamic function have not been elucidated. In 2003, the G-protein-coupled receptor Mas was identified as an endogenous receptor for Ang-(1-7) (Santos et al. 2003) . More recently, a significantly lower urine flow (UF) and fractional sodium excretion (FE Na ) were observed in euvolaemic Mas-deficient mice, thereby indicating the important role played by this receptor in the regulation of basal sodium and water excretion (Pinheiro et al. 2009 ). Furthermore, Mas receptor mRNA has been detected in rat proximal tubular cells (Su et al. 2006) , which further implicates its specific role in the transport of sodium and water at that site.
We have previously demonstrated that the natriuretic and diuretic responses to acute renal interstitial Ang-(1-7) infusion were enhanced when the renin-angiotensin system (RAS) was stimulated by a low-sodium diet and diminished when the RAS was suppressed by a high-sodium diet (O'Neill et al. 2013) . Although underlying mechanisms have yet to be elucidated fully, changes in the level of intrarenal Mas receptor expression may provide an explanation. Indeed, the chronic administration of a high-sodium diet has been shown to decrease Mas receptor expression in the renal cortex of obese Zucker rats (Samuel et al. 2012) and spontaneously hypertensive rats (Varagic et al. 2010) . In contrast, Samuel et al. (2012) observed a tendency for Mas receptor protein expression to be upregulated in the renal cortex of lean Zucker control rats. However, to our knowledge the impact of dietary sodium manipulation on Mas receptor expression in normal Wistar rats has yet to be established. In the context of our previous observations, it may well be that a low-sodium diet increases renal Mas receptor expression, thereby increasing the responsiveness of the kidney to the exogenous infusion of Ang-(1-7). The opposite might well be observed when rats are placed on a high-sodium diet.
Alternatively, the situation may be more complex and the level of activation of receptors other than Mas may be indirectly involved in mediating the renal excretory actions of Ang-(1-7). Indeed, past studies have demonstrated that the suppression of the RAS is characterized by a reduction in circulating (Douglas & Catt, 1976; Imig et al. 1999) and intrarenal (Fox et al. 1992; Ingert et al. 2002 ) levels of Ang II. In the context of our previous study (O'Neill et al. 2013 ), these observations suggest that the counter-regulatory capacity of Ang-(1-7) might be lost when endogenous Ang II levels are diminished. Moreover, in vitro studies in HEK cells provide evidence that Ang-(1-7) can counter-regulate the actions of Ang II through a direct interaction with Ang II type 1 (AT 1 ) receptors (Galandrin et al. 2016) . Thus, it may well be that exogenous Ang-(1-7) only has a natriuretic and diuretic action via the Mas receptor when Ang II/AT 1 receptor-induced reabsorption of sodium and water is at an appreciable/heightened level. Therefore, it is possible that the magnitude of renal excretory and haemodynamic actions of Ang-(1-7) could be modulated by the degree of Ang II-induced AT 1 receptor stimulation.
Thus, the aim of the present study was twofold: (i) to examine how the intrarenal actions of Ang-(1-7) might be modified after pharmacological inhibition of intrarenal AT 1 and Mas receptors in the milieu of an unstimulated and stimulated RAS; and (ii) to determine whether the renal excretory and haemodynamic actions of Ang-(1-7) during different levels of sodium intake were directly dependent on the level of activation of intrarenal Mas and AT 1 receptors.
Methods

Animals
Male Wistar rats (250-350 g) were obtained from Harlan (Bicester, UK) and maintained under a 12 h-12 h light-dark regimen at 20 ± 3°C in the Biological Services Unit, University College Cork. The animals were maintained on a normal-sodium diet (Harlan-Teklad, Bicester, UK; 0.3% Na + ); a high-sodium diet (Lillico, Dorking, UK; 3% Na + ); or a low-sodium diet (Lillico; 0.03% Na + ) for 2 weeks before experimentation. The diets differed only in terms of their NaCl content, and the concentrations of all other food constituents, such as vitamins, minerals, proteins, fats and carbohydrates, were similar across all three diets. All experimental procedures were performed under the European Community Directive 86/609/EC and were approved by the local animal experimentation ethical committee at University College Cork (AEEC: 2011/028).
Surgical protocol
Rats were fasted overnight but did have access to water. Anaesthesia was induced with 1 ml of a chloraloseurethane mixture (16.5 and 250 mg ml −1 , respectively, I.P.) and maintained using bolus I.V. doses of 0.05 ml every 30 min. A tracheostomy was carried out to ensure a patent airway. Cannulae were inserted into the right femoral vein to facilitate the infusion of sustaining saline (3 ml h −1 J. O'Neill and others of NaCl 9 g l −1 ) and, subsequently, saline containing fluorescein isothiocyanate (FITC)-inulin (3 ml h −1 of FITC-inulin, 2 g l −1 ; Sigma-Aldrich, USA), and the right femoral artery to permit the measurement of mean arterial pressure (MAP) and heart rate (HR) and the collection of blood samples. The kidney was exposed by a flank incision and prepared as previously described by Ahmeda & Johns, 2012 and O'Neill et al. 2013) . A small cannula was inserted ß4.5 mm into the rostral pole of the kidney to allow saline or Ang-(1-7) to be infused at 1 ml h −1 . Drugs infused into the kidney in the present study diffused into both the cortex and the medulla (n = 3). Lissamine Green validated this method of infusion. Staining was evident in both the cortex and the medulla, but the degree of staining appeared to be greater in the medulla. These observations are in agreement with previous reports (Ahmeda & Johns, 2012) . A 1.5 h post-surgical stabilization period was given before the commencement of all experiments. At the end of each experiment, animals were killed by an anaesthetic overdose.
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Experimental protocol 1
This experimental protocol was carried out in rats receiving either a normal-or low-sodium diet (Fig. 1A) . A sequence of four 20 min clearance periods was undertaken, with two clearances (C1 and C2) before and two (C3 and C4) during the renal interstitial infusion of Ang-(1-7) (50 ng min −1 ; Sigma-Aldrich, USA). A period of 45 min was given before initiating C3 and C4. Arterial blood samples were taken to acquire plasma samples before and after each pair of clearances. The dose of Ang-(1-7) used in the present study was chosen on the basis of those used by others (Bürgelová et al. 2002) .
Experimental protocol 2
This experimental protocol was carried out in rats receiving either a normal-or low-sodium diet (Fig. 1B) . A sequence of six 20 min clearance periods was undertaken, with two clearances (C1 and C2) during the renal interstitial infusion of saline vehicle, two clearances during the renal interstitial infusion of either the AT 1 receptor antagonist, losartan (17 µg min −1 ; Sigma-Aldrich, USA), or the Mas receptor antagonist, A-779 (5 µg min −1 ; Sigma-Aldrich, USA; C3 and C4), and two clearances during the renal interstitial co-infusion of losartan or A-779 together with Ang-(1-7) (C5 and C6). Losartan or A-779 was infused for a period of 30 min before the commencement of C3 and C4. Losartan + Ang-(1-7) or A-779 + Ang-(1-7) were co-infused for a period of 45 min before the commencement of C5 and C6. Arterial blood samples were taken immediately before C1 and after C2 and immediately after C4 and C6. The doses of A-779 and losartan used in the present study were chosen on the basis of those used by others (Bürgelová et al. 2002; Li et al. 2006; Fig. 1B) .
Control protocol
The time control protocol was carried out in rats receiving either a normal-sodium (n = 5) or low-sodium diet (n = 4). Six 20 min clearance periods were undertaken during the renal interstitial infusion of saline vehicle (Fig. 1C ).
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Summary of animal groups (renal functional studies)
Group 1: normal-sodium diet, with acute intrarenal Ang-(1-7) infusion (n = 6). Group 2: low-sodium diet, with acute intrarenal Ang-(1-7) infusion (n = 8). Group 3: normal-sodium diet, with acute intrarenal losartan infusion followed by co-infusion of losartan with Ang-(1-7) (n = 6). Group 4: low-sodium diet, with acute intrarenal losartan infusion followed by co-infusion of losartan with Ang-(1-7) (n = 6). Group 5: normal-sodium diet, with acute intrarenal A-779 infusion followed by co-infusion of A-779 with Ang-(1-7) (n = 6). Group 6: low-sodium diet, with acute intrarenal A-779 infusion followed by co-infusion of A-779 with Ang-(1-7) (n = 6). Group 7: normal-sodium diet, with acute intrarenal saline infusion (time control; n = 5). Group 8: low-sodium diet, with acute intrarenal saline infusion (time control; n = 4).
Analytical techniques
The sodium concentration of both plasma and urine samples was determined by flame photometry (Model 410C; Ciba, Corning, Halstead, UK). The glomerular filtration rate (GFR) was calculated as the clearance of FITC-inulin. The FITC-inulin concentration of the urine and plasma samples was determined using a fluorometric multilabel counter plate reader (Victor 2; Wallac, Boston, MA, USA). Urine flow was determined gravimetrically. The FE Na was given by: sodium clearance/GFR × 100. Blood samples (0.4 ml) were centrifuged at 16,000g for 1 min; 75 µl of plasma was removed for analysis, and heparinized saline (0.2 ml heparin 5,000 i.u. ml −1 in 50 ml saline) of equal volume was added to the remaining red cells and immediately returned to the animal. A blood pressure transducer (Spectramed, Oxnard, CA, USA) and an amplifier (Grayden Electronics, Birmingham, UK) operated in conjunction with a computer (Power Macintosh 8600/250; Apple, USA) and appropriate software (LabVIEW 4; National Instruments, Austin, TX, USA) to monitor and record blood pressure and heart rate. 
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After completion of the experiment, the animal was killed using an anaesthetic overdose.
Renal cortical and medullary Mas receptor expression
Preparation of renal cortex and medulla. After 2 weeks on a low-, normal-or high-sodium diet, both left and right kidneys were removed from anaesthetized rats, which were subsequently killed with an I.V. anaesthetic overdose. Kidneys were immediately put on ice. The renal cortex and medulla were dissected, flash frozen in liquid nitrogen and stored at −80°C. Renal cortical and medullary tissues were homogenized using homogenization buffer (10 mM Tris and 25 mM sucrose; 0.1 g tissue in 1000 µl buffer) and a tissue homogenizer (Omni International, Kennesaw, GA, USA). The procedure was carried out on ice, and a protease inhibitor cocktail (10 µl in 1 ml of homogenization buffer; Sigma-Aldrich, USA) was added to the tissue before homogenization. A bicinchoninic acid (BCA) assay (Bio-Rad, Hercules, CA, USA) was then performed on the tissue to quantify total protein content.
Western blotting protocol. Renal cortical protein extracts from rats on low-(n = 5), normal-(n = 4) and high-sodium diets (n = 5) and renal medullary protein extracts from rats on either a low-(n = 5) or high-sodium diet (n = 4) were loaded into wells (30 µg protein per well) on a 5% stacking gel and separated on a 10% resolving gel according to their molecular weight using SDS-PAGE (Bio-Rad). Proteins were subsequently transferred from the gel onto polyvinylidene difluoride (PVDF) membrane (Merc, Millipore, Darmstadt, Germany) using the semidry transfer method (Trans Blot SD; Bio-Rad). The efficiency of transfer was determined by applying a Ponceau S (Sigma-Aldrich, USA) stain to the membrane following transfer. The membrane was blocked for ß1 h in 5% milk in 1× Tris-buffered saline (TBS) Tween (Sigma-Aldrich, USA) at room temperature. Finally, the membrane was incubated overnight with a primary antibody (AT 1 1-S; Mas receptor antibody, 1:1500 dilution; Alomone Labs, Jerusalem, Israel; AAR-013) at 4°C. The selectivity of the anti-Mas receptor antibody was tested by co-incubating the antibody with the control antigen.
The Mas receptor has a predicted molecular weight of ß45 kDa.
Immunodetection, visualization and quantification. The membrane was washed thoroughly (four 5 min washes in 1× TBS Tween on an orbital shaker) before and after a 1 h incubation period with an anti-rabbit secondary antibody (1:2000 dilution in 5% milk in 1× TBS Tween). The protein of interest was visualized using chemiluminescence and band intensities were quantified using densitometry software (ImageJ; National Institutes of Health, Bethesda, MD, USA). To correct for any variations in protein loading and transfer, the band intensities of the proteins of interest were then normalized to the intensities of the Ponceau S staining proteins in the corresponding lanes on the transfer membrane, which were also measured by densitometric analysis (Romero-Calvo et al. 2010) .
Renal cortical and medullary Ang-(1-7) concentration
Preparation of renal cortex and medulla. Renal cortical and medullary samples from low-, high-and normalsodium-fed rats were weighed out, added to a protease inhibitor cocktail (2 µl of stock) and homogenized as described above. However, the buffer used to homogenize these tissues was ice-cold PBS (0.02 mol l −1 , pH 7.4), and the tissue to buffer ratio was 1 µg to 1 µl, i.e. 200 µg of tissue in 200 µl of PBS. After homogenization, the samples were sonicated on ice for 10 s to disrupt cell membranes further. Thereafter, the homogenates were centrifuged for 15 min at 1500g, and the resulting supernatants were stored in aliquots at −80°C.
Angiotensin-(1-7) enzyme-linked immunosorbent assay.
An Ang-(1-7) enzyme-linked immunosorbent assay kit purchased from My Biosource (San Diego, CA, USA) was used to measure Ang-(1-7) levels in the renal cortex and medulla of rats receiving a normal-(n = 5), high-(n = 5) or low-sodium diet (n = 5).
Statistical analysis
Functional data were analysed using a 2 Prism). One-way ANOVA with Fisher's LSD post hoc test was used to analyse intrarenal Ang-(1-7) levels across dietary groups. A one-way repeated-measures ANOVA was used to analyse saline time control data. Statistical significance was taken when P < 0.05. All data are presented as means ± SD.
Results
Intrarenal infusion of antagonists
Immediately before their co-infusion with Ang-(1-7), either losartan or A-779 was infused alone, and the individual impact of each antagonist upon haemodynamic and excretory function was measured and recorded in both normal-and low-sodium groups. This was done to establish the extent to which antagonists altered each parameter before their co-infusion with Ang-(1-7) ( Table 1) .
Intrarenal losartan infusion (Table 1)
The intrarenal infusion of losartan reduced MAP by 8 ± 5.5% in rats receiving a normal-sodium diet and by 8 ± 11% in rats receiving a low-sodium diet (both P < 0.05). The GFR was not altered by the intrarenal infusion of losartan in either group. In contrast, intrarenal AT 1 receptor blockade increased UF by 1.7-fold in normal rats (P < 0.05) and by 1.6-fold in low-sodium-fed rats. Intrarenal losartan infusion had a natriuretic effect in both dietary groups; intrarenal AT 1 receptor blockade increased absolute sodium excretion (U Na V) by 1.8-fold in rats receiving a normal-sodium diet (P < 0.05) and by twofold in rats receiving a low-sodium diet. Intrarenal infusion of losartan increased FE Na by 1.7-fold in rats receiving a normal-sodium diet (P < 0.05) and by twofold in rats receiving a low-sodium diet.
Intrarenal A-779 infusion (Table 1) The intrarenal infusion of A-779 had no significant effect on MAP, UF, U Na V or FE Na in either dietary group. However, intrarenal Mas receptor blockade did increase GFR by 27 ± 35% in rats receiving a normal-sodium diet (P < 0.05) but was without significant effect on this parameter in rats receiving a low-sodium diet. 
or Mas receptor inhibition on Ang-(1-7)-induced reductions in tubular sodium reabsorption in rats receiving either (A) normal-sodium (NS) or (B) low-sodium (LS) diet
Abbreviation: FE Na , fractional sodium excretion. * P < 0.05 versus corresponding baseline. 
Intrarenal Ang-(1-7) infusion
The intrarenal infusion of Ang-(1-7) caused small reductions in MAP of 4 ± 5% in rats receiving a normalsodium diet (P < 0.05) but was without significant effect on this parameter in rats receiving a low-sodium diet ( Fig. 2A and B) . Intrarenal Ang-(1-7) infusion had no effect on GFR in the normal-sodium group but significantly increased this parameter in the low-sodium group (P < 0.05; Fig. 3A and B) by ß37 ± 21%. Angiotensin-(1-7) infusion significantly increased UF by 2.2-fold in rats receiving a normal-sodium diet and by 2.8-fold in rats receiving a low-sodium diet (both P < 0.05; Fig. 4A and B) . Angiotensin-(1-7) induced a robust natriuresis in both groups. Intrarenal Ang-(1-7) infusion increased U Na V by 2.9-fold in the normal-sodium-fed rats (P < 0.05) and by some 6.1-fold in the low-sodium group (P < 0.05; Fig. 5A and B), while concomitantly there was a 2.7-fold increase in FE Na in rats receiving a normal-sodium diet and a fourfold increase in this parameter in rats receiving a low-sodium diet (both P < 0.05; Fig. 6A and B).
Intrarenal co-infusion of Ang-(1-7) with losartan or A-779
Immediately after the infusion of either losartan or A-779 alone, Ang-(1-7) was co-infused with either antagonist, and the impact on haemodynamic and excretory function was measured and recorded in both dietary groups. The haemodynamic and excretory responses to Ang-(1-7) were compared in the absence and presence of each antagonist. The MAP ( Fig. 2A and B) and GFR ( Fig. 3A and B) during the intrarenal co-infusion of losartan or A-779 and Ang-(1-7) were similar to that observed during the singular infusion of either losartan or A-779 in either dietary group. Importantly, Ang-(1-7) had no effect on GFR during either intrarenal AT 1 or Mas receptor blockade in rats receiving a low-sodium diet (interaction, P = 0.0892; Fig. 3B ).
Angiotensin-(1-7)-induced increases in UF were completely blocked in the presence of losartan or A-779 in rats receiving a normal-sodium diet (interaction, P < 0.01; Fig. 4A ). In rats receiving a low-sodium diet, Ang-(1-7) increased UF by only 1.5-fold in the presence of losartan, whereas Ang-(1-7)-induced increases in UF were blocked in the presence of A-779 (Fig. 4B) .
Angiotensin-(1-7)-induced increases in U Na V were absent during intrarenal AT 1 or Mas receptor inhibition (interaction, P < 0.001) in rats receiving a normal-sodium diet (Fig. 5A ). In the low-sodium group, Ang-(1-7) increased U Na V by only twofold during intrarenal AT 1 receptor blockade (P < 0.05) but had no significant effect on U Na V during intrarenal Mas receptor blockade (Fig. 5B) .
Importantly, the magnitude of the Ang-(1-7)-induced increases in FE Na was significantly less during intrarenal AT 1 or Mas receptor inhibition in rats receiving a normalor low-sodium diet (for both, interaction, P < 0.001; Fig. 6A and B) .
Saline time control experiments
The continuous infusion of saline over the course of the protocol had no significant effect on any of the parameters measured in the present study (Table 2 ).
Angiotenisn-(1-7) concentrations in the renal cortex and medulla of rats receiving a low-, normal-or high-sodium diet Angiotensin-(1-7) concentrations were 2.6-fold higher in the renal cortex of animals on a low-sodium diet relative to those on a normal-sodium diet (Fig. 7) . Conversely, the chronic administration of a high-sodium diet for 2 weeks did not impact upon Ang-(1-7) levels in the renal cortex (Fig. 7) . Angiotensin-(1-7) levels in the renal medulla were not different across dietary groups (data not shown).
Mas receptor expression in the renal cortex of rats receiving a low-, normal-or high-sodium diet
Mas receptor expression in the renal cortex was not altered by the administration of a low-sodium diet (Fig. 8A) . Mas receptor expression tended to be upregulated in the -(1-7) concentration in the renal cortex of rats receiving a low-, normal-or high-sodium diet * P < 0.05 comparing Ang-(1-7) levels in renal the cortex of animals receiving a normal-sodium diet versus a low-sodium diet. † P < 0.05 comparing Ang-(1-7) levels in the renal cortex of animals receiving a high-sodium diet versus a low-sodium diet.
renal cortex of rats receiving a high-sodium diet but this did not reach statistical significance (P = 0.1338; Fig. 8B ).
Mas receptor expression in the renal medulla of rats receiving a low-or high-sodium diet Mas (Fig. 9) receptor expression in the renal medulla of rats receiving a low-or high-sodium diet did not differ significantly.
Control antigen: Mas receptor antibody
The band corresponding to the Mas receptor (ß45 kDa) did not appear when the anti-Mas receptor antibody was co-incubated with the control antigen (Fig. 10) in the renal cortex of rats receiving either a low-or high-sodium diet, indicating the specificity of this antibody for the Mas receptor.
Discussion
The aim of this study was to determine whether the differences in the excretory responses to Ang-(1-7) previously observed by O'Neill et al. (2013) during dietary sodium manipulation could be related to changes in the regulation of renal angiotensin receptors and the renal production of endogenous Ang-(1-7). The first new finding was that the enhanced urinary excretion of sodium observed in animals on a low-sodium diet during intrarenal Ang-(1-7) infusion was associated with heightened intrarenal Ang-(1-7) levels at the outset of experimentation. This association strongly suggests that the natriuretic response to exogenous Ang-(1-7) in the milieu of a stimulated RAS was heightened because the endogenous Ang-(1-7) concentration in the kidney was higher in these conditions at baseline. Second, Ang-(1-7)-induced natriuresis and diuresis was inhibited during intrarenal AT 1 receptor blockade and during intrarenal Mas receptor blockade. These findings demonstrate that both AT 1 and Mas receptors mediate the renal excretory actions of Ang-(1-7). The precise mechanism by which both receptors mediate these actions remains unclear and requires further investigation.
In agreement with past reports (Vallon et al. 1998; Bürgelová et al. 2002) , intrarenal A-779 administration inhibited Ang-(1-7)-induced natriuresis, indicating that these actions are mediated by intrarenal Mas receptors. We additionally observed that the degree to which A-779 blocked the natriuretic and diuretic actions of Ang-(1-7) was similar in both dietary groups. Moreover, renal Mas receptor protein expression was not affected by the low-sodium diet. Together, these data indicate that manipulating dietary sodium in this way does not alter Mas receptor expression was normalized against total protein, which was detected using Ponceau S. Ponceau S-stained membrane was the loading control; BM, biomarker lane; and n refers to the number of animals used in each group. the sensitivity or expression of renal Mas receptors. In the context of our previous study (O'Neill et al. 2013) , it is clear that the enhanced diuretic and natriuretic responses to Ang-(1-7) observed in animals on a low-sodium diet are not likely to be explained by alterations in the expression and/or activity of renal Mas receptors.
However, the stimulation of the RAS with a low-sodium diet did impact upon intrarenal Ang-(1-7) levels, which were markedly increased in the renal cortex. These observations to a degree support those of Hamming et al. (2008) , who demonstrated that feeding a low-sodium diet reduced the angiotensin-converting enzyme (ACE)/ACE2 ratio in the rat kidney, which could theoretically potentiate intrarenal Ang-(1-7) levels [ACE degrades Ang- (1-7) ; thus, when ACE activity is reduced so too is the degradation of Ang-(1-7) (Hamming et al. 2008) ]. Indeed, the present observations indicate that heightened Ang-(1-7) levels in the renal cortex at the outset of experimentation were clearly associated with the large Ang-(1-7)-induced natriuresis observed in animals on a low-sodium diet. Moreover, these associations are consistent with the fact that the majority of sodium transporters (sodium/hydrogen cation exchanger, NHE3, Na + , K + -ATPase; López Ordieres et al. 1998; Castelo-Branco et al. 2013) inhibited by Ang-(1-7) are located in the renal cortex. We previously demonstrated that Ang-(1-7)-induced natriuresis and diuresis were diminished when the RAS was suppressed by a high-sodium diet. The mechanisms underlying these observations are currently unclear. Thus, the approach taken in the present study was to determine whether pharmacological inhibition of AT 1 receptors might also diminish the natriuretic/diuretic actions of Ang-(1-7). Intrarenal administration of the AT 1 receptor antagonist losartan caused a natriuresis and diuresis in both the normal-and low-sodium dietary groups (Table 1) . These data are consistent with the findings of others in dogs, rats and water-loaded mice (Heller & Horachek, 1997; Wang et al. 1997; Pinheiro et al. 2004) . Importantly, when the intrarenal AT 1 receptors were blocked, the natriuretic and diuretic actions of exogenously infused Ang-(1-7) were diminished in rats receiving a low-sodium diet and completely absent in the control animals, the latter (being the observation that Ang (1-7) induced natiruresis and diuresis was inhibited in control animals) being consistent with previous reports in anaesthetized dogs (Heller et al. 2000) . Thus, AT 1 receptor blockade induced a diuresis Mas receptor expression was normalized against total protein, which was detected using Ponceau S. Ponceau S-stained membrane was the loading control; BM, biomarker lane; and n refers to the number of animals used in each group. and natriuresis, which was not further increased by the concomitant infusion of Ang-(1-7). Furthermore, the blunted excretory actions of Ang-(1-7) during intrarenal AT 1 receptor blockade resemble our previous observations in rats fed a high-sodium diet (O'Neill et al. 2013) . These pharmacological findings suggest that intrarenal AT 1 receptors influence the excretory responses to Ang-(1-7) in an important manner. The precise way in which AT 1 receptors contribute to Ang-(1-7)-induced diuresis and natriuresis is unclear and beyond the scope of the present study. However, within the current literature there is evidence to suggest that Ang-(1-7) and/or its receptor Mas can interact with the AT 1 receptor and inhibit its activation either by acting directly at the AT 1 receptor and acting as a natural biased agonist (Galandrin et al. 2016) or via Mas-AT 1 receptor dimerization (Kostensis et al. 2005) . In the context of the present study, it may well be that AT 1 receptors must be functional for mediating the natriuretic and diuretic effects of Ang-(1-7).
Mas receptor protein expression tended to be upregulated in the renal cortex in rats on a high-sodium diet, in agreement with the findings of others in lean Zucker control animals (Samuel et al. 2012) . These data are not consistent with our previous functional data, which demonstrated that the natriuretic and diuretic actions of Ang-(1-7) were diminished in rats receiving a high-sodium diet (O'Neill et al. 2013) . One must acknowledge here that the measurement of Mas receptor expression only provides information about changes in the relative abundance of Mas receptor protein in the tissue. However, it does not give insight into how many of these receptors were expressed on the cell membrane versus how many were internalized. Thus, one cannot rule out the possibility that the diminished response to renal interstitial Ang-(1-7) infusion observed in our previous study in animals fed a high-sodium diet (O'Neill et al. 2013 ) was attributable to a reduction in the sensitivity of tubular epithelial cells to Ang-(1-7).
Angiotensin-(1-7)-induced increases in GFR were absent in the presence of A-779 in the low-sodium group, indicating that Mas receptors play a role in mediating this vascular response in the milieu of a stimulated RAS. These observations are consistent with previous reports in vivo in rats (Bürgelová et al. 2005) . The A-779-induced increases in GFR observed in the present study are in direct contrast to the findings of others in anesthetized rats (Vallon et al. 1998; Bürgelová et al. 2002 Bürgelová et al. , 2005 and are possibly confounded by the effect of tubuloglomerular feedback. Moreover, Tetzner et al. 2016 recently demonstrated that the depressor effects of Ang-(1-7) are also mediated by MrgD receptors. Thus, the observed increase in GFR in the present study could also be a result of Ang-(1-7)/MrgD-mediated vasodilatation.
It is important to acknowledge that there are limitations to the experimental approach used in the present study. Possible over-spill of losartan into the systemic circulation caused reductions in MAP, which most probably masked the expected renal haemodynamic effects of losartan (Wang et al. 1997) . Moreover, the dose of losartan administered was not increased to offset increased intrarenal Ang II in the rats receiving a low-sodium diet (Fox et al. 1992; Ingert et al. 2002; Sica et al. 2005) . Thus, losartan-induced increases in sodium and water excretion were of similar magnitude in both dietary groups. This also explains why Ang-(1-7)-induced diuresis and natriuresis were not diminished to a greater degree in the presence of losartan in the low-sodium group.
In conclusion, the main important finding of the present study was that Ang-(1-7)-induced natriuresis and diuresis were influenced by AT 1 receptor functionality in the milieu of an unstimulated and stimulated RAS. Collectively, these findings show that both intrarenal AT 1 and Mas receptors play a role in mediating the natriuretic and diuretic actions of Ang-(1-7). Future studies are needed to examine in more detail the relative contribution of each receptor subtype in mediating the intrarenal actions of Ang-(1-7) in the kidney. This is particularly true given that MrgD receptors have now also been identified as Ang-(1-7) receptors (Tetzner et al. 2016) . Gaining a deeper understanding of such interactions could help to promote the development of therapeutic agents for the treatment of hypertension and chronic kidney disease.
